DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20160397

A study to compare the clinical outcome of sublingual and vaginal misoprostol in the medical management of missed miscarriage in first trimester

Akanksha Lamba, Ramanjeet Kaur, Priya Sardana

Abstract


Background: Objective of the study was to compare the efficacy, outcome and side effects of sublingual and vaginal misoprostol for the medical management of missed miscarriage.

Methods: Fifty women diagnosed as having missed miscarriage of gestational age less than 20 weeks were randomized to vaginal or sublingual route of drug administration by lottery method (random sampling) A total number of 25 cases in each of the two groups were considered. Women in Group A received 400 microgram of misoprostol sublingually every four hours for a maximum of 5 doses and those in Group B received 400 microgram of misoprostol vaginally every four hours for a maximum of 5 doses.  The primary outcome measures were, complete evacuation of products of conception, mean induction to delivery time and the occurrence of side effects.

Results: In complete evacuation rates between the sublingual misoprostol and the vaginal misoprostol groups there was no statistically significant difference. Mean induction to delivery time was also similar for both groups as was the total number of doses required. As far as Side effects were concerned, Diarrhea was the major frequent side effect of sublingual misoprostol seen in 32% cases against only 12% cases with vaginal misoprostol.

Conclusions: The effectiveness of Sublingual misoprostol is comparable to that of vaginal misoprostol for medical management of missed miscarriage but is associated with an increased risk of side effects especially diarrhoea.


Keywords


Misoprostol, Sublingual, Vaginal, Missed miscarriage

Full Text:

PDF

References


Alberman E. Spontaneous abortion: epidemiology. In:Stabile S, Grudzinkas G, Chard T, editors. Spontaneous abortion: diagnosis and treatment. London: Springer- Verlag; 1992:9-20.

Gemzell-Danielsson K, Ho PC, Gómez Ponce de León R, Weeks A, Winikoff B. Misoprostol to treat missed abortion in the first trimester. Intern J Gynecol Obstet. 2007;99(2):S182-5.

Cunningham FG, Leveno KJ, Gilstrap LC. III, Hauth JC, Wenstrom KD, Bloom SL. Williams Obstetrics. 22nd Edition, McGraw-Hill; 2005.

Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod. 2004;19:266-71.

Robson SC, Kelly T, Howel D, Deverill M, Hewison J, Lie MLS. Randomized preference trial of medical versus surgical termination of pregnancy less than 14 weeks gestation (TOPS). Health Technol Assess. 2009;13:53.

Chung TKH, Cheung LP, Lau WC, Haines CJ, Chang AM. Spontaneous abortion: a medical approach to management. Aust N Z J Obstet Gynaecol. 1994;34:432-6.

Koopersmith TB, Mishell DR. The use of misoprostol for termination of early pregnancy. Contraception. 1996;57:237-42.

Zhang J, Giles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005;353:761-9.

Bernard KG, Cooperburg PL. Sonographic differentiation between blighted ovum and early viable pregnancy. Am J Roentgenol. 1985;144:597-602.

Management of post abortion hemorrhage, society of family planning, guidelines, 2013.

Management of early pregnancy miscarriage, Clinical practice guidelines, Institute of obstetricians and gynecologists. Royal college of physicians of Ireland and directorate of strategy and clinical programmes, Health Service Executive. Guideline no 10. April 2012.

Cunningham FG; Williams Obstetrics. 23rd edition, McGraw Hill Company; 2010:215-234.

Sonsanoh A, Chullapram T. Comparison of sublingual and vaginal misoprostol for termination of early pregnancy failure. Thai J Obstet Gynaecol. 2014;22:128-36.

Tang OS, Lau WNT, Ng EHY, Lee SWH, Ho PC. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages. Hum Reprod. 2003;18:176-81.

Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM et al for the National Institute of Child Health Human Development (NICHD) management of early pregnancy failure trial. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. New England J Med. 2005;353(8):761-9.

Latif S, Usmani SY, Fatima N. Comparison of sublingual and vaginal routes of misoprostol in termination of first trimester missed abortion. Headache. 3:10.

Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reproduct. 2002;17:332-6.

Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side effects. Int J gynecol Obstet. 2007;99(2):S160-7.

Hamoda H, Ashok PW, Pow J, Flett GM, Templeton A. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. Contraception. 2003;68:335-8.

Tang OS, Miao BY, Ho PG. Pilot study on the use of repeated doses of sublingual in termination of pregnancy: efficacy and acceptability. Hum Reprod. 2002;17:654-8.